Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SCLEROSIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 14914 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Griffith, T; Lezama, JL; Sanders, S; Adelman, HM
      A man with history of skin lesions and seizures

      HOSPITAL PRACTICE
    2. Nuyens, G; De Weerdt, W; Ketelaer, P; Spaepen, A; Staes, F
      Torque variations during repeated passive isokinetic knee movements in persons with multiple sclerosis

      JOURNAL OF REHABILITATION MEDICINE
    3. Morisco, F; Mazziotti, G; Rotondi, M; Tuccillo, C; Iasevoli, P; Del Buono, A; Sorvillo, F; Amato, G; Marmo, R; Caporaso, N; Carella, C
      Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C

      DIGESTIVE AND LIVER DISEASE
    4. Rosati, G
      The prevalence of multiple sclerosis in the world: an update

      NEUROLOGICAL SCIENCES
    5. Allen, IV; McQuaid, S; Mirakhur, M; Nevin, G
      Pathological abnormalities in the normal-appearing white matter in multiple sclerosis

      NEUROLOGICAL SCIENCES
    6. Soderstrom, M
      Clues to the immunopathogenesis of multiple sclerosis by investigating untreated patients during the very early stage of disease

      NEUROLOGICAL SCIENCES
    7. Gout, O
      Vaccinations and multiple sclerosis

      NEUROLOGICAL SCIENCES
    8. Reis, J; Dietemann, JL; Warter, JM; Poser, CM
      A case of multiple sclerosis triggered by organic solvents

      NEUROLOGICAL SCIENCES
    9. Pugliatti, M; Sotgiu, S; Solinas, G; Castiglia, P; Rosati, G
      Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory

      NEUROLOGICAL SCIENCES
    10. Sotgiu, S; Pugliatti, M; Solinas, G; Castiglia, P; Sanna, A; Rosati, G
      Immunogenetic heterogeneity of multiple sclerosis in Sardinia

      NEUROLOGICAL SCIENCES
    11. Serra, C; Sotgiu, S; Mameli, G; Pugliatti, M; Rosati, G; Dolei, A
      Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia

      NEUROLOGICAL SCIENCES
    12. Savettieri, G; Ragonese, P; Aridon, P; Salemi, G
      Epidemiology of multiple sclerosis in Sicily

      NEUROLOGICAL SCIENCES
    13. Granieri, E; Casetta, I; Tola, MR; Ferrante, P
      Multiple sclerosis: infectious hypothesis

      NEUROLOGICAL SCIENCES
    14. Pryse-Phillips, W
      Twenty questions about multiple sclerosis clinical trials methodologies

      NEUROLOGICAL SCIENCES
    15. Filippi, M
      Non-conventional MR techniques to monitor the evolution of multiple sclerosis

      NEUROLOGICAL SCIENCES
    16. Durelli, L; Oggero, A; Verdun, E; Barbero, P; Pipieri, A; Isoardo, G; Ricci, A; Clerico, M; Bradac, G; Bergamasco, B; Bergui, M
      Interferon-beta dose and efficacy: the OPTIMS study

      NEUROLOGICAL SCIENCES
    17. Lugaresi, A; Caporale, C; Farina, D; Marzoli, F; Bonanni, L; Muraro, PA; De Luca, G; Iarlori, C; Gambi, D
      Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis

      NEUROLOGICAL SCIENCES
    18. van der Veen, RC
      Nitric oxide and T helper cell immunity

      INTERNATIONAL IMMUNOPHARMACOLOGY
    19. McMurray, RW
      Estrogen, prolactin, and autoimmunity: actions and interactions

      INTERNATIONAL IMMUNOPHARMACOLOGY
    20. Ossege, LM; Sindern, E; Patzold, T; Malin, JP
      Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis

      INTERNATIONAL IMMUNOPHARMACOLOGY
    21. Hedlund, G; Link, H; Zhu, J; Xiao, BG
      Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system

      INTERNATIONAL IMMUNOPHARMACOLOGY
    22. Brown, KA
      Factors modifying the migration of lymphocytes across the blood-brain barrier

      INTERNATIONAL IMMUNOPHARMACOLOGY
    23. Ohno, T; Shimizu, T; Kato, S; Hayashi, H; Hirai, S
      Effect of tamsulosin hydrochloride on sympathetic hyperactivity in amyotrophic lateral sclerosis

      AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    24. Rao, RKA; Yeragani, VK
      Decreased chaos and increased nonlinearity of heart rate time series in patients with panic disorder

      AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    25. Whitacre, CC
      Sex differences in autoimmune disease

      NATURE IMMUNOLOGY
    26. Taneja, V; David, CS
      Lessons from animal models for human autoimmune diseases

      NATURE IMMUNOLOGY
    27. Wandstrat, A; Wakeland, E
      The genetics of complex autoimmune diseases: non-MHC susceptibility genes

      NATURE IMMUNOLOGY
    28. Weiner, HL
      The fine line between autoimmune and allergic encephalomyelitis

      NATURE IMMUNOLOGY
    29. Pedotti, R; Mitchell, D; Wedemeyer, J; Karpuj, M; Chabas, D; Hattab, EM; Tsai, M; Galli, SJ; Steinman, L
      An unexpected version of horror autotoxicus: anaphylactic shock to a self peptide

      NATURE IMMUNOLOGY
    30. Gerard, C; Rollins, BJ
      Chemokines and disease

      NATURE IMMUNOLOGY
    31. Kondo, T; Cortese, I; Markovic-Plese, S; Wandinger, KP; Carter, C; Brown, M; Leitman, S; Martin, R
      Dendritic cells signal T cells in the absence of exogenous antigen

      NATURE IMMUNOLOGY
    32. Heckman-Stone, C; Stone, C
      Pain management techniques used by patients with multiple sclerosis

      JOURNAL OF PAIN
    33. Karst, M; Fink, M; Wagner, T; Conrad, I
      Transdermal fentanyl: Little absorption in two patients with systemic sclerosis?

      PAIN MEDICINE
    34. Thomson, G
      An overview of the genetic analysis of complex diseases, with reference totype I diabetes

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    35. Lai, FPL; Tsukada, Y; Ichikawa, H; Dunster, K; Sentry, JW; Toh, BH
      Autoantibody to DNA excision repair enzyme hMYH in a patient with rheumatic disease

      CLINICAL IMMUNOLOGY
    36. Newman, R; Hariharan, K; Reff, M; Anderson, DR; Braslawsky, G; Santoro, D; Hanna, N; Bugelski, PJ; Brigham-Burke, M; Crysler, C; Gagnon, RC; Dal Monte, P; Doyle, ML; Hensley, PC; Reddy, MP; Sweet, RW; Truneh, A
      Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees

      CLINICAL IMMUNOLOGY
    37. Gausling, R; Trollmo, C; Hafler, DA
      Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis

      CLINICAL IMMUNOLOGY
    38. Constantinescu, CS; Hilliard, B; Ventura, E; Wysocka, M; Showe, L; Lavi, E; Fujioka, T; Scott, P; Trinchieri, G; Rostami, A
      Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively

      CLINICAL IMMUNOLOGY
    39. Patel, DD; Zachariah, JP; Whichard, LP
      CXCR3 and CCR5 ligands in rheumatoid arthritis synovium

      CLINICAL IMMUNOLOGY
    40. Kivioja, J; Ozenci, V; Rinaldi, L; Kouwenhoven, M; Lindgren, U; Link, H
      Systemic immune response in whiplash injury and ankle sprain: Elevated IL-6 and IL-10

      CLINICAL IMMUNOLOGY
    41. Sporici, RA; Perrin, PJ
      Costimulation of memory T-cells by ICOS: A potential therapeutic target for autoimmunity?

      CLINICAL IMMUNOLOGY
    42. Sporici, RA; Beswick, RL; von Allmen, C; Rumbley, CA; Hayden-Ledbetter, M; Ledbetter, JA; Perrin, PJ
      ICOS ligand costimulation is required for T-cell encephalitogenicity

      CLINICAL IMMUNOLOGY
    43. van der Vliet, HJJ; von Blomberg, BME; Nishi, N; Reijm, M; Voskuyl, AE; van Bodegraven, AA; Polman, CH; Rustemeyer, T; Lips, P; van den Eertwegh, AJM; Giaccone, G; Scheper, RJ; Pinedo, HM
      Circulating V alpha 24(+) V beta 11(+) NKT cell numbers are decreased in awide variety of diseases that are characterized by autoreactive tissue damage

      CLINICAL IMMUNOLOGY
    44. Sami, N; Bhol, KC; Beutner, EH; Plunkett, RW; Leiferman, KM; Foster, CS; Ahmed, AR
      Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies

      CLINICAL IMMUNOLOGY
    45. Parisi, V; Uccioli, L
      Visual electrophysiological responses in persons with type 1 diabetes

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    46. Rewald, E; Francischetti, MM; Nydegger, UE
      IVIG-pools: regulatory gifts - Transiting from harmony toward harmonious immunoglobulins: Why? and why not?

      TRANSFUSION AND APHERESIS SCIENCE
    47. Cozzi, F; Marson, P; Rosada, M; De Silvestro, G; Bullo, A; Punzi, L; Todesco, S
      Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory markers reflecting disease activity

      TRANSFUSION AND APHERESIS SCIENCE
    48. Kanazawa, I
      How do neurons die in neurodegenerative diseases?

      TRENDS IN MOLECULAR MEDICINE
    49. Schwartz, M; Kipnis, J
      Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries

      TRENDS IN MOLECULAR MEDICINE
    50. Torchilin, VP; Iakoubov, LZ; Estrov, Z
      Antinuclear autoantibodies as potential antineoplastic agents

      TRENDS IN IMMUNOLOGY
    51. Clark, WM; Lutsep, HL
      Potential of anticytokine therapies in central nervous system ischaemia

      EXPERT OPINION ON BIOLOGICAL THERAPY
    52. Waxman, SG
      Transcriptional channelopathies: An emerging class of disorders

      NATURE REVIEWS NEUROSCIENCE
    53. Yong, VW; Power, C; Forsyth, P; Edwards, DR
      Metalloproteinases in biology and pathology of the nervous system

      NATURE REVIEWS NEUROSCIENCE
    54. Cleveland, DW; Rothstein, JD
      From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS

      NATURE REVIEWS NEUROSCIENCE
    55. Dredge, BK; Polydorides, AD; Darnell, RB
      The splice of life: Alternative splicing and neurological disease

      NATURE REVIEWS NEUROSCIENCE
    56. Andersen, PM; Spitsyn, VA; Makarov, SV; Nilsson, L; Kravchuk, OI; Bychkovskaya, LS; Marklund, SL
      The geographical and ethnic distribution of the D90A CuZn-SOD mutation in the Russian Federation

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    57. Bilak, MM; Corse, AM; Kuncl, RW
      Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    58. Chioza, BA; Ujfalusy, A; Csiszar, K; Leigh, PN; Powell, JF; Radunovic, A
      Mutations in the lysyl oxidase gene are not associated with amyotrophic lateral sclerosis

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    59. Beghi, E; Logroscino, G; Micheli, A; Millul, A; Perini, M; Riva, R; Salmoiraghi, F; Vitelli, E
      Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    60. Santos-Bento, M; de Carvalho, M; Evangelista, T; Luis, MLS
      Sympathetic sudomotor function and amyotrophic lateral sclerosis

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    61. Miller, RG
      Examining the evidence about treatment in ALS/MND

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    62. Cedarbaum, JM; Stambler, N
      Disease status and use of ventilatory support by ALS patients

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    63. Portet, F; Cadilhac, C; Touchon, J; Camu, W
      Cognitive impairment in motor neuron disease with bulbar onset

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    64. Bromberg, MB; Anderson, F; Davidson, M; Miller, RG
      Assessing health status quality of life in ALS: Comparison of the SIP/ALS-19 with the ALS functional rating scale and the short form-12 health survey(TM)

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    65. Dal Bello-Haas, V; Andrews-Hinders, D; Richer, CB; Blakely-Adams, C; Hanson, J; Hammel, J; Kelly, D; Kloos, A; Pioro, EP; Powazki, RD; Wheeler, T; Mitsumoto, H
      Development, analysis, refinement, and utility of an interdisciplinary amyotrophic lateral sclerosis database

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    66. Swash, M
      ALS 2000: the past points to the future

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    67. Mitsumoto, H
      Clinical trials: present and future

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    68. Meininger, V
      Clinical trials: the past, a lesson for the future

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    69. Munsat, TL
      Slowing down ALS - is this good or bad?

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    70. Nobile-Orazio, E; Carpo, M; Meucci, N
      Are there immunologically treatable motor neuron diseases?

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    71. Borasio, GD
      Palliative care in ALS: searching for the evidence base

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    72. Andersen, PM
      Genetics of sporadic ALS

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    73. Gellera, C
      Genetics of ALS in Italian families

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    74. Appel, SH; Beers, D; Siklos, L; Engelhardt, JI; Mosier, DR
      Calcium: the Darth Vader of ALS

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    75. Beck, M; Karch, C; Wiese, S; Sendtner, M
      Motoneuron cell death and neurotrophic factors: Basic models for development of new therapeutic strategies in ALS

      AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
    76. Pantelidis, P; McGrath, DS; Southcott, AM; Black, CM; du Bois, RM
      Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific

      RESPIRATORY RESEARCH
    77. Czuwara-Ladykowska, J; Makiela, B; Smith, EA; Trojanowska, M; Rudnicka, L
      The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis

      ARTHRITIS RESEARCH
    78. Scheja, A; Akesson, A; Geborek, P; Wildt, M; Wollheim, CB; Wollheim, FA; Vischer, UM
      Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)

      ARTHRITIS RESEARCH
    79. Jirholt, J; Lindqvist, AKB; Holmdahl, R
      The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes

      ARTHRITIS RESEARCH
    80. Bakhiet, M; Tjernlund, A; Mousa, A; Gad, A; Stromblad, S; Kuziel, WA; Seiger, A; Andersson, J
      RANTES promotes growth and survival of human first-trimester forebrain astrocytes

      NATURE CELL BIOLOGY
    81. Enskat, R; Deaney, CN; Glickman, S
      Systemic effects of intravesical atropine sulphate

      BJU INTERNATIONAL
    82. Francombe, J; Carter, S; Hershman, MJ
      The aetiology and epidemiology of faecal incontinence

      HOSPITAL MEDICINE
    83. Rajasekaran, BA; Shovlin, D; Lord, P; Kelly, CA
      Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis

      RHEUMATOLOGY
    84. Coleiro, B; Marshall, SE; Denton, CP; Howell, K; Blann, A; Welsh, KI; Black, CM
      Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine

      RHEUMATOLOGY
    85. Keberle, M; Tony, HP; Hau, M; Kessler, C; Jahns, R; Jenett, M
      Colour Doppler ultrasound of the nailbed: an objective tool for monitoringresponses to vasodilatory treatment of connective tissue disorders?

      RHEUMATOLOGY
    86. Isaacs, JD
      From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies

      RHEUMATOLOGY
    87. Furst, DE; Clements, PJ; Wong, WK; Mayes, MD; Wigley, F; White, B; Weisman, M; Barr, W; Moreland, L; Martin, R; Medsger, TA; Steen, V; Collier, D; Weinstein, A; Lally, E; Varga, J; Weiner, SR; Andrews, B; Abeles, M; Peter, JB; Seibold, JR
      Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial

      RHEUMATOLOGY
    88. Yamane, K; Ihn, H; Kubo, M; Kuwana, M; Asano, Y; Yazawa, N; Tamaki, K
      Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma

      RHEUMATOLOGY
    89. Herrick, AL; Illingworth, KJ; Hollis, S; Gomez-Zumaquero, JM; Tinahones, FJ
      Antibodies against oxidized low-density lipoproteins in systemic sclerosis

      RHEUMATOLOGY
    90. Nishijima, C; Sato, S; Hasegawa, M; Nagaoka, T; Hirata, A; Komatsu, K; Takehara, K
      Renal vascular damage in Japanese patients with systemic sclerosis

      RHEUMATOLOGY
    91. Sari-Kouzel, H; Hutchinson, CE; Middleton, A; Webb, F; Moore, T; Griffin, K; Herrick, AL
      Foot problems in patients with systemic sclerosis

      RHEUMATOLOGY
    92. MacGregor, AJ; Canavan, R; Knight, C; Denton, CP; Davar, J; Coghlan, J; Black, CM
      Pulmonary hypertension in systemic sclerosis: risk factors for progressionand consequences for survival

      RHEUMATOLOGY
    93. La Montagna, G; Baruffo, A; Pasquali, D; Bellastella, A; Tirri, G; Sinisi, AA
      Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis

      RHEUMATOLOGY
    94. Knight, LR; Smeathers, JE; Isdale, AH; Helliwell, PS
      Evaluating the cutaneous involvement in scleroderma: torsional stiffness revisited

      RHEUMATOLOGY
    95. Istok, R; Czirjak, L; Lukac, J; Stancikova, M; Rovensky, J
      Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon

      RHEUMATOLOGY
    96. Artlett, CM; Miller, FW; Rider, LG
      Persistent maternally derived peripheral microchimerism is associated withthe juvenile idiopathic inflammatory myopathies

      RHEUMATOLOGY
    97. Allanore, Y; Borderie, D; Hilliquin, P; Hernvann, A; Levacher, M; Lemarechal, H; Ekindjian, OG; Kahan, A
      Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophagecells

      RHEUMATOLOGY
    98. Wan, MC; Moore, T; Hollis, S; Herrick, AL
      Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody

      RHEUMATOLOGY
    99. Sato, S; Hamaguchi, Y; Hasegawa, M; Takehara, K
      Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis

      RHEUMATOLOGY
    100. Tormey, VJ; Bunn, CC; Denton, CP; Black, CM
      Anti-fibrillarin antibodies in systemic sclerosis

      RHEUMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:13:58